Shareholders Equity: The sum of preferred and common equity items.
bioMerieux (BMXMF) had Shareholders Equity of $4.56B for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$2.71B |
|
-- |
|
$1.70B |
|
$6.24B |
|
$1.23B |
|
$377.87M |
|
$458.92M |
|
$1.69B |
|
$4.56B |
|
$3.23B |
|
|
Shareholders Equity |
$4.56B |
-- |
|
| Cash Flow Statement Financials | |
$722.09M |
|
$-389.34M |
|
$-230.06M |
|
$360.77M |
|
$478.40M |
|
$117.62M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|